Stargardt or Macular Dystrophy Disease in Iran - Eye Stem Cell Center

Stargardt or Macular Dystrophy Disease in Iran

Explanation of Stargardt Disease and Macular Dystrophy

Stargardt disease is an eye condition that impairs eyesight in kids and teens. Since it is an inherited disease, children inherit it from their parents. The macula, the center area of the retina responsible for sharp, high-detail vision, is most affected by these conditions. Although they will not exhibit symptoms, a person who carries the gene from only one parent is a carrier for Stargardt illness. Although they are extremely uncommon, other types of Stargardt disease require a gene from just one parent to manifest symptoms.

Although it can happen in adults, Stargardt illness usually strikes during childhood or adolescent. Typically, the patients’ vision deteriorates, they have trouble reading, and their color vision is compromised. Macular dystrophies, such as Best disease and pattern dystrophy, also present with similar manifestations but at different rates.

The Challenge in Iran

In Iran, these ocular diseases are increasingly being identified with increased awareness and better diagnostic methods. Yet, therapeutic interventions are still very limited, and the majority of patients must depend on low-vision devices or compensatory systems. The absence of a true curative treatment has rendered these disorders highly disabling for patients and professionals alike.

The Promise of Stem Cell Therapy

Stem cell therapy is on the brink of being a potential cure for Stargardt and macular dystrophy. By creating retinal pigment epithelial (RPE) cells from stem cells, researchers hope to replace the faulty cells in the patient’s retina. Clinical trials across the globe have proved that RPE cells derived from stem cells can restore some vision and halt the progression of the disease.

Role of the Eye Stem Centre in Iran

The Iran eye stem centre is not only a treatment facility but also a meeting point for innovation, clinical research, and collaboration. With ongoing investment in this area, the center will be able to provide solutions for thousands of patients with vision loss.

With regenerative medicine advancing, patients in Iran with macular dystrophy and Stargardt disease now have hope restored. With advanced stem cell research and dedicated attention at the eye stem centre in Iran, the future brightens for those previously confronted with irreversible blindness.